Maximal cytoreductive surgery and high dose cisplatin chemotherapy for advanced ovarian cancer.

Abstract

Fifty-eight stage III patients treated at The Jikei University Hospital were analysed retrospectively, in order to clarify the combination effect of maximal cytoreductive surgery and high dose cisplatin based chemotherapy in advanced ovarian cancer. They were divided into 4 groups by treatment they received which was as follows: Group A (n = 25); total… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.